Alcidion Group Limited · ASX:ALC
Alcidion — Shareholder Meeting (November 2017)
9 slides from Alcidion's shareholder meeting presentation, Nov 24, 2017
Slide 1: Alcidion Group Limited Annual General Meeting
Alcidion Group Limited Annual General Meeting 24 November 2017 Better, Faster Decisions Ms Rebecca Wilson Director 1
Slide 2: Alcidion: A Company Snapshot
ALCIDION : A COMPANY SNAPSHOT ● Alcidion’s core asset is the Miya software platform Market & financial overview A$m – Creates decision intelligence from real-time data ASX listed Feb 2016 ALC taken from disparate healthcare IT systems Share price (17/11/17) $0.048 – Miya : better, faster decisions M
Slide 3: Alcidion's Niche – Miya's Value Add
ALCIDION’S NICHE – MIYA’S VALUE ADD Miya means BETTER, FASTER decisions to improve patient care and business outcomes What is Miya? • Miya is a differentiated decision intelligence platform that : – PUSHES key clinical information to users rather than requiring user to PULL the information – integra
Slide 4: Miya: Product Platform & Sites
MIYA : PRODUCT PLATFORM & SITES A broad suite of Clinical Decision Support products Software modules that work together with Product overview: Customer sites: existing hospital IT systems • Emergency Dept management • Royal Melbourne hospital • Clinical dashboards & ED • Footscray hospital whiteboar
Slide 5: Miya's Position: Decision Intelligence Space
MIYA’S POSITION : DECISION INTELLIGENCE SPACE Next Key players in the space Generation Predictive Analytics, Applications: Performance Metrics and High Analytics & Decision Intelligence Alcidion is focused on Outcome Miya Platform pushing further into the Layer higher value next generation “decision
Slide 6: Revenue Model
REVENUE MODEL Alcidion charges clients an upfront fee & on-going fees Upfront implementation & customisation fee: • Initial fee charged for: - system design - implementation - training Annuity revenue / ongoing fee: • Payable quarterly or annually in advance • Maintenance fee • Expected to grow subs
Slide 7: Second Stage Revenue Growth Strategy
SECOND STAGE REVENUE GROWTH STRATEGY Focus on building long term contracts and annuity revenues 1 Public hospital sector 2 Private hospital sector 3 Business & product 4 Geographical expansion (Aust. & NZ) (Aust. & NZ) development • Renewed focus on sales • Business strategy for Strategic M&A • Entr
Slide 8: Anticipated News Flow
ANTICIPATED NEWS FLOW Targeted Alcidion news flow next twelve-months: New contract wins – public & private hospital sector Strategic M&A opportunities Entry into new international markets Completion of complementary cloud based product platform Growth in revenues Upcoming market communications: • An
Slide 9: Summary: Investment Highlights
SUMMARY : INVESTMENT HIGHLIGHTS Miya - INNOVATIVE & PROVEN TECHNOLOGY: • Differentiated product - enabling better, faster decisions • Established reference sites • Integrates with all major hospital IT systems • $20m invested to date in core technology platform EXPOSURE TO FAST GROWTH DIGITAL HEALTH